{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:13:20Z","timestamp":1791213200379,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.bone.2010.06.001","type":"journal-article","created":{"date-parts":[[2010,6,11]],"date-time":"2010-06-11T10:50:46Z","timestamp":1276253446000},"page":"583-590","source":"Crossref","is-referenced-by-count":47,"title":["Osteoclasts in neurofibromatosis type 1 display enhanced resorption capacity, aberrant morphology, and resistance to serum deprivation"],"prefix":"10.1016","volume":"47","author":[{"given":"Eetu","family":"Heerv\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria H.","family":"Alanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirkku","family":"Peltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommi","family":"Kuorilehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teuvo","family":"Hentunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalervo","family":"V\u00e4\u00e4n\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Peltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2010.06.001_bib1","series-title":"Neurofibromatosis: Phenotype, Natural History and Pathogenesis","author":"Riccardi","year":"1986"},{"key":"10.1016\/j.bone.2010.06.001_bib2","first-page":"1","article-title":"The neurofibromatoses: classification, clinical features and genetic councelling","volume":"16","author":"Huson","year":"2008"},{"key":"10.1016\/j.bone.2010.06.001_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archderm.141.1.71","article-title":"Prevalence of neurofibromatosis 1 in German children at elementary school enrollment","volume":"141","author":"Lammert","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.bone.2010.06.001_bib4","first-page":"172","article-title":"National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987","volume":"1","year":"1988","journal-title":"Neurofibromatosis"},{"key":"10.1016\/j.bone.2010.06.001_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0092-8674(90)90253-B","article-title":"A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations","volume":"62","author":"Cawthon","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.bone.2010.06.001_bib6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","article-title":"The neurofibromatosis type 1 gene encodes a protein related to GAP","volume":"62","author":"Xu","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.bone.2010.06.001_bib7","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0888-7543(91)90017-9","article-title":"cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product","volume":"11","author":"Marchuk","year":"1991","journal-title":"Genomics"},{"key":"10.1016\/j.bone.2010.06.001_bib8","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/ajmg.a.33045","article-title":"Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options","volume":"149A","author":"Elefteriou","year":"2009","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.bone.2010.06.001_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/01241398-198601000-00015","article-title":"Osseous manifestations of neurofibromatosis in childhood","volume":"6","author":"Crawford","year":"1986","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.bone.2010.06.001_bib10","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s00198-004-1801-4","article-title":"Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body","volume":"16","author":"Kuorilehto","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2010.06.001_bib11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00198-005-1940-2","article-title":"Decreased bone mineral density in patients with neurofibromatosis 1","volume":"16","author":"Lammert","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2010.06.001_bib12","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1097\/00007632-199712010-00014","article-title":"Spine update. The management of scoliosis in neurofibromatosis","volume":"22","author":"Kim","year":"1997","journal-title":"Spine"},{"issue":"Suppl 1","key":"10.1016\/j.bone.2010.06.001_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2106\/JBJS.F.00836","article-title":"The immature spine in type-1 neurofibromatosis","volume":"89","author":"Crawford","year":"2007","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.bone.2010.06.001_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U","article-title":"Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1, 728 patients","volume":"70","author":"Friedman","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.bone.2010.06.001_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/088307380201700812","article-title":"Neurofibromatosis 1: clinical review and exceptions to the rules","volume":"17","author":"Young","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.bone.2010.06.001_bib16","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1203\/PDR.0b013e31816fee45","article-title":"Evidence of increased bone resorption in neurofibromatosis type 1 using urinary pyridinium crosslink analysis","volume":"63","author":"Stevenson","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.bone.2010.06.001_bib17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejmg.2007.04.001","article-title":"Periapical cemental dysplasia is common in women with NF1","volume":"50","author":"Visnapuu","year":"2007","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.bone.2010.06.001_bib18","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2214\/ajr.133.6.1135","article-title":"Fibrous lesions in the lower extremities in neurofibromatosis","volume":"133","author":"Mandell","year":"1979","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.bone.2010.06.001_bib19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1359\/JBMR.040130","article-title":"NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos","volume":"19","author":"Kuorilehto","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2010.06.001_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1369\/jhc.5A6784.2005","article-title":"NF1 gene expression in mouse fracture healing and in experimental rat pseudarthrosis","volume":"54","author":"Kuorilehto","year":"2006","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.bone.2010.06.001_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1741-7015-6-21","article-title":"Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin","volume":"6","author":"Kolanczyk","year":"2008","journal-title":"BMC Med"},{"key":"10.1016\/j.bone.2010.06.001_bib22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bone.2007.11.006","article-title":"Recent insights into bone development, homeostasis, and repair in type 1 neurofibromatosis (NF1)","volume":"42","author":"Schindeler","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.06.001_bib23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bone.2008.10.050","article-title":"Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression","volume":"44","author":"Leskel\u00e4","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.06.001_bib24","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1172\/JCI29092","article-title":"Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions","volume":"116","author":"Yang","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2010.06.001_bib25","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bone.2005.01.022","article-title":"Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning","volume":"36","author":"Yu","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.06.001_bib26","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/hmg\/ddl208","article-title":"Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem\/progenitor cells","volume":"15","author":"Wu","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bone.2010.06.001_bib27","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/hmg\/ddm032","article-title":"Multiple roles for neurofibromin in skeletal development and growth","volume":"16","author":"Kolanczyk","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bone.2010.06.001_bib28","doi-asserted-by":"crossref","first-page":"32356","DOI":"10.1074\/jbc.M414213200","article-title":"Possible role of direct Rac1-Rab7 interaction in ruffled border formation of osteoclasts","volume":"280","author":"Sun","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2010.06.001_bib29","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/hmg\/ddm366","article-title":"Rac1 mediates the osteoclast gains-in-function induced by haploinsufficiency of Nf1","volume":"17","author":"Yan","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bone.2010.06.001_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/258325a0","article-title":"Investigation of cell lineage in bone using a chimaera of chick and quial embryonic tissue","volume":"258","author":"Kahn","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.bone.2010.06.001_bib31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.142.3.651","article-title":"Control of bone resorption by hematopoietic tissue. The induction and reversal of congenital osteopetrosis in mice through use of bone marrow and splenic transplants","volume":"142","author":"Walker","year":"1975","journal-title":"J Exp Med"},{"key":"10.1016\/j.bone.2010.06.001_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/321079a0","article-title":"In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population","volume":"321","author":"Scheven","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.bone.2010.06.001_bib33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2141.1999.01491.x","article-title":"Human osteoclasts derive from CD14-positive monocytes","volume":"106","author":"Massey","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bone.2010.06.001_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bone.2010.06.001_bib35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/345442a0","article-title":"The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene","volume":"345","author":"Yoshida","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bone.2010.06.001_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/ar1857","article-title":"Osteoclasts; culprits in inflammatory osteolysis","volume":"8","author":"Teitelbaum","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bone.2010.06.001_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1034\/j.1600-0854.2003.40206.x","article-title":"Osteoclast ruffled border has distinct subdomains for secretion and degraded matrix uptake","volume":"4","author":"Mulari","year":"2003","journal-title":"Traffic"},{"key":"10.1016\/j.bone.2010.06.001_bib38","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jbmr.5650060806","article-title":"Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro","volume":"6","author":"Lakkakorpi","year":"1991","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2010.06.001_bib39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.prp.2006.03.006","article-title":"Vasculopathy in two cases of NF1-related congenital pseudarthrosis","volume":"202","author":"Kuorilehto","year":"2006","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.bone.2010.06.001_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-59745-104-8_2","article-title":"Osteoclast culture and resorption assays","volume":"455","author":"Bradley","year":"2008","journal-title":"Meth Mol Biol"},{"key":"10.1016\/j.bone.2010.06.001_bib41","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1093\/clinchem\/44.11.2290","article-title":"Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides","volume":"44","author":"Christgau","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.bone.2010.06.001_bib42","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF00299317","article-title":"The effects of bisphosphonates on the resorption cycle of isolated osteoclasts","volume":"55","author":"Selander","year":"1994","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2010.06.001_bib43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2141.2000.02379.x","article-title":"Characterization of osteoclast precursors in human blood","volume":"111","author":"Shalhoub","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bone.2010.06.001_bib44","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.4049\/jimmunol.0804314","article-title":"GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras\/ERK pathway","volume":"183","author":"Lee","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.bone.2010.06.001_bib45","doi-asserted-by":"crossref","first-page":"33662","DOI":"10.1074\/jbc.M109.010785","article-title":"Breast cancer-derived factors stimulate osteoclastogenesis through the Ca2+\/protein kinase C and transforming growth factor-beta\/MAPK signaling pathways","volume":"284","author":"Tiedemann","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2010.06.001_bib46","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/sj.cdd.4402057","article-title":"The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways","volume":"14","author":"Shapira","year":"2007","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bone.2010.06.001_bib47","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/jnci\/93.14.1062","article-title":"Blocking oncogenic Ras signaling for cancer therapy","volume":"93","author":"Adjei","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bone.2010.06.001_bib48","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1523-1747.2000.00882.x","article-title":"New function for NF1 tumor suppressor","volume":"114","author":"Koivunen","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.bone.2010.06.001_bib49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00691998","article-title":"Neurofibromatosis tumor and skin cells in culture","volume":"61","author":"Peltonen","year":"1983","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.bone.2010.06.001_bib50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/1523-1747.ep12466155","article-title":"A computed image analyzing system for quantitation of melanocyte morphology in caf\u00e9-au-lait macules of neurofibromatosis","volume":"88","author":"Ishida","year":"1987","journal-title":"J Invest Dermatol"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328210012949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328210012949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T17:18:46Z","timestamp":1591377526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328210012949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S8756328210012949"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2010.06.001","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}